Pictet Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

Pictet Bank & Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,660	Closed	-$521K	–	64
2019 Q1	$521K	Sell	4,660 -5,864	-56%	-$643K	0.23%	55
2018 Q4	$1.01M	Sell	10,524 -2,970	-22%	-$315K	0.41%	46
2018 Q3	$1.65M	Hold	13,494	–	–	0.51%	38
2018 Q2	$1.48M	Sell	13,494 -96	-0.7%	-$10.3K	0.51%	39
2018 Q1	$1.45M	Hold	13,590	–	–	0.52%	41
2017 Q4	$1.45M	Buy	13,590 +2,880	+27%	+$308K	0.43%	45
2017 Q3	$1.19M	Buy	+10,710	New	+$1.14M	0.36%	52
2017 Q1	–	Sell	-2,853	Closed	-$252K	–	90
2016 Q4	$252K	Buy	+2,853	New	+$260K	0.08%	76
2015 Q4	–	Sell	-3,000	Closed	-$303K	–	95
2015 Q3	$303K	Hold	3,000	–	–	0.11%	79
2015 Q2	$369K	Buy	+3,000	New	+$359K	0.12%	62

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pictet Bank & Trust's IBB Position: Q2 2019 in Review

Pictet Bank & Trust sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 4,660 shares — an estimated $521K sold.

Pictet Bank & Trust first reported a position in IBB in Q2 2015 and held it in 10 quarters. The position peaked at $1.65M in Q3 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

Pictet Bank & Trust reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
Pictet Bank & Trust sold 4,660 iShares Biotechnology ETF shares in Q2 2019, an estimated $521K.
Pictet Bank & Trust first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 10 quarters.
Pictet Bank & Trust's iShares Biotechnology ETF position peaked at $1.65M in Q3 2018.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Pictet Bank & Trust's 13F filing for Q2 2019, filed 7 Aug 2019.